Inpatient costs associated with alcohol-associated liver disease (ALD) increased from 2016 to 2019, according to a study in ...

The first oral GLP-1 weight-loss pill, which contains semaglutide, became available nationwide Monday, January 5.

Delayed remission with advanced therapies in IBD is not associated with worse 1-year clinical or endoscopic outcomes.

Researchers assessed the risk for serious infection during pregnancy and postpartum based on TNF inhibitor exposure among women with chronic inflammatory disease.

Nutritional issues such as ARFID are highly prevalent among patients with SSc and can lead to poor outcomes and other ...

Researchers evaluated whether pregnancy complications, early childhood characteristics, and tobacco-related exposures were ...

The Wyoming Supreme Court blocked 2 abortion ban laws that they found to violate a state constitution amendment.

Continuing 5-ASA after escalation to advanced therapy in ulcerative colitis is associated with lower odds of clinical remission.

Background mucosal inflammation at CRC diagnosis is linked to worse recurrence-free and cancer-specific survival in ulcerative colitis.

Long-term surveillance of branch-duct IPMN shows a 5.5% 10-year risk for pancreatic cancer, with cyst wall thickening emerging as a key independent predictor.

GLP-1RA therapy significantly reduces the risk for new-onset heart failure in patients with type 2 diabetes or obesity, regardless of weight loss.

The Food and Drug Administration has approved Nereus (tradipitant) for the prevention of vomiting induced by motion in adults.